Farma

Haltopen
20.10.2021 kl 08:46 1925

Particle-Enhanced Turbidimetric Immunoassay Emerges as Preferred Solution to Address Soaring Burden of Influenza and Tuberculosis
Published: Oct 20, 2021

- As per Fact.MR, the global particle-enhanced turbidimetric immunoassays market is projected to exhibit strong growth during the forecast period, from 2021 and 2031.

- increasing adoption of PETIAs kits and regents for bulk antibody testing of novel diseases such as Ebola and COVID-19 is exponentially driving the market.

- Rising prevalence of infectious diseases such as influenza, tuberculosis, and chickenpox among others will emerge as a chief growth driver. According to the World Health Organization (WHO), around 10 million cases of tuberculosis were reported across the world, causing nearly 1.5 million fatalities in 2020.

This has resulted in higher demand for quick and effective diagnosis of the aforementioned diseases, which is expected to create growth opportunities for the market.

- Also, increasing PETIA application across endocrinology, cardiology, and oncology for quantitative measurement of proteins, pathogens, and other molecules in body fluids, such as plasma will aid the growth in the market.

Key Drivers

Surging demand for quick results providing diagnostic devices for quantitative testing of COVID-19 across the countries such as China, India, the U.S., and others are driving the sales of particle-enhanced turbidimetric immunoassays.

Increasing research and development activities across pharmaceutical and biotechnological companies for the development of novel drugs and bionics for various disease therapeutics is propelling the demand.

Enda en av disse betalings-markedsanalysene. Men, noen interessante poeng:
- Gentian har nå en template for antistoff-testing (COVID) og denne kan trolig brukes på andre viruser (influensa, ebola, vannkopper, etc)
- Gentian har allerede NT-proBNP på vei (cardiology)
- Gentian har markør innen onkologi i pipeline
- Gentian lanserer COVID antistofftest dette kvartalet (surging demand)

Tenk hva Gentian kunne fått til med akselerert vekst..

https://www.biospace.com/article/particle-enhanced-turbidimetric-immunoassay-emerges-as-preferred-solution-to-address-soaring-burden-of-influenza-and-tuberculosis/
Redigert 20.10.2021 kl 08:55

Rapportér innlegg

Vennligst skriv inn kommentar på hva du mener er upassende og trykk send. Dersom kommentar ikke er nødvendig, vennligst trykk send direkte.
E-postadressen brukes kun for å få kontakt med deg i forbindelse med advarselen.
E-postadressen brukes kun for å få kontakt med deg i forbindelse med advarselen.